On this page
FKRP
fukutin related protein
The FKRP gene provides instructions for producing fukutin-related protein, which is crucial for the normal glycosylation of alpha-dystroglycan, a protein vital for muscle and brain function. The FKRP gene is responsible for encoding fukutin-related protein (FKRP), an enzyme that plays a key role in the glycosylation pathway.
FKRP is located on the long (q) arm of chromosome 19, at band 19q13.32. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 19 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The FKRP gene, or fukutin related protein, is involved in a vital cellular process known as glycosylation. This gene's product, the FKRP protein, is found in various body tissues, with high concentrations in the brain, heart, and skeletal muscles. Its proper function is integral to normal muscle and brain development.
What the gene does
The FKRP protein functions primarily within the Golgi apparatus, a cellular organelle responsible for modifying newly synthesised proteins. Its main role is in glycosylation, specifically by adding a molecule called ribitol 5-phosphate to the sugar chain of alpha (α)-dystroglycan. This glycosylation is fundamental for α-dystroglycan to perform its critical functions. In skeletal muscles, properly glycosylated α-dystroglycan helps to stabilise and protect muscle fibres. In the brain, it is involved in directing the migration of nerve cells during early developmental stages, ensuring correct brain structure and function. FKRP therefore plays a crucial part in the structural integrity of muscle tissue and neurological development.
Video: Genetics 101
Chromosome location
The FKRP gene is located on chromosome 19, specifically at position 19q13.32. This genomic location positions FKRP within the long arm of chromosome 19. The gene encodes a protein composed of 495 amino acids.
Protein structure
The FKRP protein has a total length of 495 amino acids. One notable feature within its structure is a Zinc finger loop, which spans amino acids 289-318. The overall domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Variants in the FKRP gene can lead to a spectrum of conditions, ranging in severity. These genetic changes can impair the normal function of the fukutin-related protein, affecting the essential glycosylation process it facilitates. The impact of these variants can vary widely depending on their specific nature and location within the gene.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1000G>T | p.Glu334Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.1020C>G | p.Tyr340Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal recessive limb-girdle muscular dystrophy type 2I |
c.1077G>A | p.Trp359Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.1208dup | p.Arg404fs | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.1216C>T | p.Gln406Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
c.159_160delinsTT | p.Arg54Trp | Pathogenic | ★★☆☆ | Autosomal recessive limb-girdle muscular dystrophy |
c.217C>T | p.Gln73Ter | Pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.265C>G | p.Pro89Ala | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
c.651_652dup | p.Val218fs | Pathogenic/Likely pathogenic | ★★☆☆ | Cardiovascular phenotype |
c.795_811del | p.Ala267fs | Pathogenic/Likely pathogenic | ★★☆☆ | Walker-Warburg congenital muscular dystrophy |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the FKRP gene are associated with a group of inherited muscle and brain disorders. The most severe condition linked to FKRP is Walker-Warburg syndrome, which manifests with profound muscle weakness and abnormalities of the brain and eyes. Other conditions include various forms of congenital muscular dystrophy and limb-girdle muscular dystrophy, all of which involve muscle weakness and, in some cases, intellectual disability or eye problems.
- Walker-Warburg syndrome Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic FKRP variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The FKRP gene is included in several expert-curated panels within the NHS Genomic Medicine Service's PanelApp. It is covered for conditions such as Acute rhabdomyolysis (R419), Arthrogryposis (R83), Congenital muscular dystrophy (R79), Foetal anomalies (R21), Hydrocephalus (R86), Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies (R82), and Paediatric or syndromic cardiomyopathy (R135). FKRP is also part of panels for Congenital disorders of glycosylation, Intellectual disability, and Malformations of cortical development.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the FKRP gene?
The FKRP gene provides instructions for the fukutin-related protein, which is critical for a process called glycosylation. This process modifies alpha-dystroglycan, a protein essential for muscle stability and brain development.
Which conditions are associated with variants in the FKRP gene?
Variants in the FKRP gene are primarily associated with a range of muscular dystrophies, including Walker-Warburg syndrome, a severe form of congenital muscular dystrophy, and limb-girdle muscular dystrophy.
Where is the FKRP gene located?
The FKRP gene is located on chromosome 19, specifically at the 19q13.32 position. This region contains the genetic instructions for the fukutin-related protein.
References
- Kanagawa M, Kobayashi K, Tajiri M. Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy. Cell reports. 2016. PMID: 26923585
- Gerin I, Ury B, Breloy I. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan. Nature communications. 2016. PMID: 27194101
- Trovato R, Astrea G, Bartalena L. Elevated serum creatine kinase and small cerebellum prompt diagnosis of congenital muscular dystrophy due to FKRP mutations. Journal of child neurology. 2014. PMID: 23420653
- Willer T, Inamori K, Venzke D. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation. eLife. 2014. PMID: 25279699
- Kava M, Chitayat D, Blaser S. Eye and brain abnormalities in congenital muscular dystrophies caused by fukutin-related protein gene (FKRP) mutations. Pediatric neurology. 2013. PMID: 24139536
- Esapa CT, McIlhinney RA, Blake DJ. Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells. Human molecular genetics. 2005. PMID: 15574464
- Boito CA, Melacini P, Vianello A. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Archives of neurology. 2005. PMID: 16344347
- Beltran-Valero de Bernabé D, Voit T, Longman C. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. Journal of medical genetics. 2004. PMID: 15121789
- Esapa CT, Benson MA, Schröder JE. Functional requirements for fukutin-related protein in the Golgi apparatus. Human molecular genetics. 2002. PMID: 12471058